We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Achieve Life Sciences Inc | NASDAQ:ACHV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.225 | 5.13% | 4.615 | 4.61 | 4.63 | 4.76 | 4.43 | 4.43 | 405,386 | 19:57:43 |
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
ARMISTICE CAPITAL, LLC |
2. Issuer Name
and
Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __ X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
510 MADISON AVENUE, 7TH FLOOR, |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
NEW YORK, NY 10022 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 6/11/2019 | S | 29724 | D | $4.39 | 1066202 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1066202 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 21118 | D | $4.29 | 1045084 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1045084 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 31897 | D | $3.30 | 1013187 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1013187 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | P | 12813 | A | $3.80 (2) | 1026000 | D (1) | |||
Common Stock | 6/11/2019 | P | 0 | A | $0 | 1026000 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 10000 | D | $3.64 | 1016000 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1016000 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 800 | D | $3.61 | 1015200 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1015200 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 5944 | D | $3.38 | 1009256 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1009256 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 2918 | D | $3.17 | 1006338 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1006338 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 2200 | D | $3.02 | 1004138 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 1004138 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 23362 | D | $3.01 | 980776 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 980776 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 11705 | D | $3.00 | 969071 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 969071 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 8082 | D | $2.91 | 960989 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 960989 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 64213 | D | $2.66 | 896776 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 896776 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 3000 | D | $2.53 | 893776 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 893776 | I | See Footnote (1) | ||
Common Stock | 6/11/2019 | S | 50000 | D | $2.57 | 843776 | D (1) | |||
Common Stock | 6/11/2019 | S | 0 | D | $0 | 843776 | I | See Footnote (1) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Remarks:
This is the first part of a Form 4 filing for the Reporting Persons. There are two parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
ARMISTICE CAPITAL, LLC
510 MADISON AVENUE, 7TH FLOOR NEW YORK, NY 10022 |
|
X |
|
|
|
Armistice Capital Master Fund Ltd.
C/O DMS CORPORATE SERVICES LTD. 20 GENESIS CLOSE, P.O. BOX 314 GRAND CAYMAN, E9 KY1-1104 |
|
X |
|
|
|
Boyd Steven
C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 7TH FLOOR NEW YORK, NY 10022 |
|
X |
|
|
Signatures
|
||
Armistice Capital, LLC By: /s/ Steven Boyd, Managing Member | 6/13/2019 | |
** Signature of Reporting Person |
Date
|
|
Armistice Capital Master Fund Ltd. By: /s/ Steven Boyd, Director | 6/13/2019 | |
** Signature of Reporting Person |
Date
|
|
/s/ Steven Boyd | 6/13/2019 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Achieve Life Sciences Chart |
1 Month Achieve Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions